IP Library Assignment 055524/0371
Patent Assignment
Reel/Frame 055524/0371

Assignment of Assignor's Interest

Recorded: 2021-03-08 Pages: 16
Assignors
CHEN, WEIRONG
Executed: 2008-07-10
FRANKLIN, LLOYD
Executed: 2008-07-10
GUAN, BING
Executed: 2008-07-10
JONES, JOHN HOWARD
Executed: 2008-07-10
KUMARAVEL, GNANASAMBANDAM
Executed: 2008-07-10
LANE, BENJAMIN
Executed: 2008-07-10
LITTKE, ADAM
Executed: 2008-07-10
LUGOVSKOY, ALEXEY
Executed: 2008-07-10
PENG, HAIRUO
Executed: 2008-07-10
POWELL, NOEL
Executed: 2008-07-10
VESSELS, JEFFREY
Executed: 2008-07-10
WYNN, THOMAS
Executed: 2008-07-10
XIN, ZHILI
Executed: 2008-07-10
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property (1)
Compounds Useful as Raf Kinase Inhibitors
Patent: 8,802,657 →
Application: 13/657,506 →
Publication: US 2013/0065858
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 14, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 054921/0863 →
Assignment of Assignor's Interest Mar 8, 2021
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0173 →
Assignment of Assignor's Interest Mar 8, 2021
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 055524/0457 →
Assignment of Assignor's Interest Mar 8, 2021
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 055524/0525 →
Merger May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →